4Azzolin L,Panciera T, Soligo S, et al. YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response[ J]. Cell, 2014, 158(1): 157-170.
5Wang F,Xiao W, Sun J, et al. MiRNA-181c inhibits EGFR-signaling- dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma[J]. Tumor Biol, 2014, 35(9): 8653-8658.
6Hatfield DL, Tsuji PA, Carlson BA, et al. Selenium and selenocysteine : roles in cancer, health, and development [ J ]. Trends Biochem Sci, 2014, 39(3): 112-120.
7Nagatsuma AK, Aizawa M, Kuwata T, et al. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma[J]. Gastric Cancer, 2015, 18(2) : 227-238.
8Fuse N,Kuboki Y, Kuwata T, et al. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients[J]. Gastric Cancer, 2016, 19(1) : 183-191.
9Misra S, Boylan M, Selvam A, et al. Redox-active selenium compounds--from toxicity and cell death to cancer treatment [ J ]. Nutrients, 2015, 7(5): 3536-3556.
10Fernandes AP, Gandin V. Selenium compounds as therapeutic agents in cancer[J]. Biochim Biophys Acta, 2015, 1850(8) : 1642-1660.
